Vaccine: Mark Harper discusses rollout targets
When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.
The European Union had a target of vaccinating fully at least 70 percent of the population in each member state by the end of the summer. However, the events of the last few weeks have put this objective in serious doubt. Thanks to a troubled procurement programme, the EU’s vaccination rate is around a fifth of Britain’s.
Vaccines are most urgently needed in Portugal – currently the world’s worst COVID-19 hotspot – but the country’s vaccine chief warned at the beginning of February that he “can’t do much more” because the EU has not procured enough jabs.
Spanish authorities stopped all vaccinations in the Madrid region for ten days starting on January 27 because of a lack of jabs.
The following day, three French regions including the Paris area faced such a shortfall that they had to suspend injections of first doses to guarantee those already vaccinated their second doses.
This came amid the European Commission’s row with AstraZeneca, which developed its jab with Oxford University. The EU envisaged some 80 million doses arriving by March but the Anglo-Swedish firm informed Brussels on January 22 that, due to problems at a factory in Belgium, it could only deliver 31 million doses in that timeframe.
The row escalated further as the EU said it would be triggering an emergency provision in the Brexit deal to control COVID-19 vaccine exports, including the possible introduction of checks at the border of Ireland and Northern Ireland to prevent shipments entering the UK.
After fierce condemnation from London, Belfast, and Dublin, the EU performed a swift U-turn.
As the recriminations continue, in an exclusive interview with Express.co.uk, French MEP Philippe Olivier, who also serves as special adviser to National Rally leader Marine Le Pen, hit out at the EU for its sluggish vaccination programme.
He said: “Everything the EU touches is a failure.
“It is true in many, many aspects.
“Starting with coal and steel and now with the vaccines…
“The EU has forgotten that being a buyer is actually a real job.
“And Brussels just doesn’t dispose of the people, the infrastructures and doesn’t have the capacity to be managing millions of vaccines all over Europe, in 27 countries.”
Mr Olivier noted: “Even MEPs were not able to see the various contracts before they were signed.
“I wasn’t shown the doses, the prices… I knew nothing about them.
JUST IN: German Chancellor admitted acting like dictator to bring in euro
“To resume, it is very expensive, it is inefficient and it has been tainted.”
Ms Le Pen’s adviser claimed his party believes in “proximity” and “proximity of decision-making and power”.
He added: “We think it is extravagant for a continental superpower to be managing this.”
In another interview with Express.co.uk, Italian MEP Antonio Maria Rinaldi echoed Mr Olivier’s claims, arguing Brexit Britain will be able to reboot its economy quicker than the bloc’s member states.
He said: “Because of this complete disaster, the EU will be the last one to leave the state of emergency.
“We will pay both in terms of death and economic recovery.
“Britain will recover much quicker and it’s all thanks to Brexit and its regained sovereignty.”
It has recently emerged that a French start-up has received an order from the UK for 40 million doses of its vaccine this week – with London to now be given priority access to the jabs over Paris and the rest of the EU.
The vaccine is expected to be in the UK by June this year but may not be available in France until 2022.
Barnier’s presidential bid torn apart by Le Pen’s aide [INSIGHT]
Biden’s trade war continues as EU winemakers urge for tariffs to end [REVEALED]
Merkel’s ‘EU fiscal plan’ could be scuppered by German Court [ANALYSIS]
President and Chief Business Officer of biotech company Valneva, Franck Grimaud, has estimated that the first vaccines will be delivered to the UK as soon as medical trials are complete, which he believes will be as early as June 2021.
However, vaccines are only likely to be available to the EU by approximately the beginning of 2022, even though the company is based in Saint-Herblain, Pays de la Loire, France.
The Council President of the Pays de la Loire region has angrily blamed French President Emmanuel Macron for a missed opportunity to provide the vaccine to local people.
President Christelle Morançais said: “It is vital that the state proves it has much more agility and reactivity when it comes to supporting and defending our companies at the forefront of fighting the virus.
“France has missed the chance of ‘its’ own Covid vaccine.”
Source: Read Full Article